Physician profile
Zachary D Post
NPI 1962443606
$1,691,555.64
in general payments reported to CMS, 2019-2025
20 companies · $202K in 2025
The $202K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233K · 2020: $194K · 2021: $225K · 2022: $247K · 2023: $403K · 2024: $187K · 2025: $202K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $610K · Consulting Fee: $145K · Travel and Lodging: $18K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $14K · Food and Beverage: $5,945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $609,738.89 |
| Consulting Fee | $145,090.33 |
| Travel and Lodging | $18,264.06 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $14,000.00 |
| Food and Beverage | $5,944.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Development Corporation | $1,013,208.51 | 2019-2025 | |
| Medical Device Business Services, INC. | $427,428.52 | 2019-2025 | Pinnacle, Actis, Velys |
| Depuy Synthes Products, INC. | $245,201.33 | 2019-2023 | Attune, Pinnacle |
| Smith+Nephew, INC. | $1,977.64 | 2019-2025 | Journey II, Real Intelligence |
| Depuy Synthes Sales INC. | $1,921.68 | 2019-2025 | Attune, Velys, Actis |
| Stryker Corporation | $798.12 | 2019-2025 | Mako, Restoration, Triathlon |
| Zimmer Biomet Holdings, INC. | $274.10 | 2019-2025 | Gel-One Cross-Linked Hyaluronate, Persona |
| Becton, Dickinson and Company | $129.18 | 2022 | |
| Ferring Pharmaceuticals INC. | $111.73 | 2019-2025 | Euflexxa |
| Arthrex, INC. | $109.60 | 2019 | |
| Eclipse Technology Solutions INC. | $87.91 | 2024 | |
| Si-Bone, INC. | $52.88 | 2021-2022 | |
| Onkos Surgical, INC. | $52.30 | 2022 | |
| Heraeus Medical, LLC. | $38.30 | 2022-2025 | |
| Ethicon US, LLC | $38.15 | 2023 | Surgicel Nu-Knit |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $35.51 | 2023 | Biobrace 23mm |
| Fidia Pharma USA INC. | $27.78 | 2025 | Hymovis |
| Kowa Pharmaceuticals America, INC. | $27.30 | 2022 | |
| Sanara Medtech INC. | $20.77 | 2024 | Biasurge |
| Abbott Laboratories | $14.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Post listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.